Prime Peptides Review 2026: TB-500 Capsules, Full GLP Trio & Specialty Blend Catalog

# Prime Peptides Review 2026: TB-500 Capsules, Full GLP Trio & Specialty Blend Catalog

> Disclaimer: All Prime Peptides products listed on Peptides.SO are sold exclusively for laboratory and in-vitro scientific research. They are not approved for human or veterinary use. This review is provided for informational and research-procurement purposes only.

Prime Peptides (primepeptides.co) is a U.S.-based research compound supplier with 21 active listings on Peptides.SO. The company distinguishes itself through several catalog features unusual in the research peptide market: a TB4-Fragment 17-23 capsule delivery format for Thymosin Beta-4 fragment research, complete GLP receptor agonist coverage across all three pharmacological generations (Semaglutide, Tirzepatide, Retatrutide), and GHK-Cu in a 120mg bulk vial at $0.625/mg — one of the more competitive per-mg copper peptide prices verified among domestic U.S. suppliers.

Company Overview

Prime Peptides operates as a multi-category research compound supplier with a catalog that covers growth hormone secretagogues, metabolic research agents, tissue healing compounds, longevity peptides, and GLP receptor agonists — five distinct research categories from 21 listings. The catalog reflects breadth strategy over depth: rather than offering 10 variants within one category, Prime Peptides provides coverage across more research biology domains, serving as a potential one-stop source for multi-axis research programs.

The primepeptides.co domain and the catalog's breadth suggest a research-professional target audience comfortable navigating across compound categories. The TB4-Frag 17-23 capsule format in particular indicates awareness of researchers who need alternative delivery-route options for study designs where reconstituted vials present logistical challenges.

Catalog & Products

GLP Receptor Research: Complete Three-Generation Coverage

Prime Peptides is one of a limited number of U.S. research suppliers offering all three GLP receptor pharmacology generations simultaneously:

Semaglutide ($125): Semaglutide is the canonical GLP-1 receptor agonist, with established research literature in glucose-stimulated insulin secretion, gastric motility, adipose tissue lipolysis, and incretin pharmacology. At $125 for a standard research vial, Prime Peptides' Semaglutide pricing is competitive relative to the $130–$249 range seen at other vendors in this review cohort.

Tirzepatide ($130): Tirzepatide adds GIP receptor co-agonism to the GLP-1 receptor base, producing differential effects on beta-cell function, adipokine secretion, and hepatic lipid metabolism compared to GLP-1 monotherapy. Research has demonstrated additive or synergistic glycemic control in clinical models. At $130, Prime Peptides prices Tirzepatide only $5 above Semaglutide — an unusual pricing relationship that favors dual-agonist procurement for researchers comparing pharmacological profiles.

Retatrutide ($140): Retatrutide extends the receptor coverage to triple agonism: GLP-1R + GIPR + GCGR (glucagon receptor). The glucagon receptor addition creates a third pharmacological dimension — direct hepatic glycogenolysis, augmented energy expenditure through UCP-1-mediated thermogenesis, and enhanced fatty acid oxidation rates. At $140, Prime Peptides' Retatrutide is among the most accessible per-unit prices verified for this compound from a U.S. domestic source. The $15 price spread between Semaglutide and Retatrutide is unusually narrow, making the full GLP trifecta achievable for research budgets that normally allow only one or two GLP compounds.

TB-500: The Capsule Format Innovation

TB-500 (Thymosin Beta-4 / TB4-Frag 17-23, 250mcg/capsule) at $85: This is perhaps the most distinctive catalog entry at Prime Peptides. Standard TB-500 presentations are lyophilized vials requiring reconstitution with bacteriostatic water before use. The capsule format provides an alternative for oral administration research models in appropriate experimental contexts — studying TB-500 peptide oral bioavailability, gastrointestinal mucosal interactions, or inflammatory bowel disease biology where systemic injection is not the preferred delivery route.

The Fragment 17-23 specification is significant: TB4-Frag 17-23 is the active actin-binding domain of Thymosin Beta-4, comprising amino acids 17-23 of the full 43-amino acid sequence. This domain is responsible for the cell motility, wound healing, and actin-sequestering activity attributed to full-length TB-500. Research using the isolated fragment allows investigation of whether the Fragment 17-23 domain is sufficient to recapitulate full-length TB-500 effects, or whether other sequence regions contribute additional signaling activity.

TB-500 Standard Vial ($85): The traditional lyophilized reconstitutable format also available for injection-route research protocols.

Together, the two TB-500 formats allow comparative delivery-route studies — a capability available from very few domestic research suppliers.

Growth Hormone Axis Research

CJC No-DAC / Ipamorelin Blend (5mg/5mg at $60): The standard GHRH/GHRP combination for GH secretagogue research. At $60 for 10mg total (5+5), this blend price is competitive relative to vendors who offer the same combination at $75–$100. The non-DAC CJC maintains physiological pulsatile GHRH receptor signaling patterns while Ipamorelin provides selective ghrelin receptor stimulation with minimal cortisol or prolactin side effects.

CJC & Ipa (another format at $85): An additional CJC/Ipamorelin combination option.

Sermorelin ($75): The native GHRH 1-29 analog for foundational pituitary GH secretion research.

Tesamorelin ($80): The 44-amino acid stabilized GHRH analog studied in visceral adipose tissue biology and body composition research.

Melanotan I ($45–$50, two formats): Melanotan I for photoprotection and melanocortin receptor biology research.

AOD-9604 ($55): Growth hormone Fragment 176-191, studied for selective lipolytic activity without anabolic GH effects.

Semax ($75): The synthetic ACTH analog studied for BDNF upregulation, neuroprotective biology, and cognitive enhancement models.

KLOW Blend: The Four-Compound Healing Stack

KLOW Blend 80mg ($140 = $1.75/mg): The KLOW Blend formulation — BPC-157, TB-500, KPV, and GHK-Cu in an 80mg combination vial — is available at $140, which computes to $1.75/mg blended. This is one of the lower KLOW pricing points verified across domestic suppliers. The combination covers distinct healing biology mechanisms:

• •BPC-157: Gastrointestinal and systemic tissue healing
• •TB-500: Actin-mediated cell motility and wound repair
• •KPV: Melanocortin anti-inflammatory signaling
• •GHK-Cu: Copper-mediated collagen synthesis and antioxidant activity

Copper Peptide: High-Volume GHK-Cu Access

GHK-Cu 120mg at $75 = $0.625/mg: This is a standout pricing point. GHK-Cu (Copper Peptide / Tripeptide-1) research encompasses wound healing, collagen and elastin synthesis, anti-inflammatory signaling, angiogenesis, and skin biology. At $0.625/mg for 120mg, Prime Peptides offers a bulk copper peptide price that is competitive with specialist cosmetic-science research suppliers. Researchers with ongoing GHK-Cu protocols find the 120mg vial format reduces reconstitution frequency relative to the 50–100mg presentations common at other vendors.

Metabolic & Longevity Research Coverage

MOTS-c ($65): The mitochondria-derived peptide studied in AMPK-mediated glucose homeostasis, fatty acid oxidation, and metabolic adaptation research.

5-Amino-1MQ ($65): NNMT inhibitor for NAD+ metabolism and adipocyte biology.

NAD+ ($100): Nicotinamide adenine dinucleotide for cellular energy metabolism and sirtuin activation research.

BPC-157 ($70): Standalone BPC-157 for gastrointestinal and tissue healing research.

Specialty Blends

PCL GLOW Blend ($120): A pharmaceutical compounding laboratory-format cosmetic peptide formulation. The GLOW Blend covers skin biology research with a compounded multi-peptide formulation designed for cosmetic-science experimental designs.

Bacteriostatic Water (30mL, limited availability at $0): Prime Peptides makes reconstitution solution available alongside compound orders when stock permits.

Pricing Analysis

Prime Peptides demonstrates competitive pricing across its GLP series in particular:

The $140 Retatrutide price is notably competitive — most vendors pricing this compound range from $139–$249. The full GLP trifecta totaling $395 (Sema + Tirz + Reta) is accessible for research programs comparing the three receptor agonist generations.

Quality & Testing Standards

Prime Peptides follows the third-party analytical testing standards standard for the quality-documented tier of U.S. research compound suppliers: HPLC purity characterization and mass spectrometry identity confirmation with COA documentation. For GLP-series compounds with complex synthesis profiles (fatty acid conjugation, multiple disulfide bonds), COA verification is particularly relevant.

The capsule format TB4-Frag 17-23 adds a quality consideration specific to encapsulation: researchers should verify that COA documentation covers the encapsulated peptide content per capsule as well as the standard purity characterization, confirming dosing consistency across the capsule batch.

Shipping & Customer Service

Prime Peptides ships domestically within the United States with standard 1–3 business day processing. The availability of bacteriostatic water (limited) alongside compound orders simplifies procurement for researchers who need reconstitution supplies without separate vendor orders. Cold-chain handling follows standard lyophilized peptide protocols.

Pros & Cons

Pros

• •Complete GLP receptor trifecta: GLP-1 only, dual GLP-1+GIP, and triple GLP-1+GIP+GCGR
• •Retatrutide at $140 is among the most accessible domestic pricing verified
• •TB4-Frag 17-23 capsule format — unique delivery-route research capability
• •GHK-Cu 120mg at $0.625/mg is highly competitive for copper peptide research
• •KLOW Blend at $1.75/mg is competitive for multi-compound healing protocols
• •CJC/Ipamorelin blend at $60 (10mg combined) is well-priced
• •Semax and AOD-9604 for neuroprotective and lipolysis research coverage
• •MOTS-c and 5-Amino-1MQ for metabolic biology stack

Cons

• •21 listings is a smaller catalog — less coverage in some specialized categories
• •No GHRP-2, GHRP-6, or Hexarelin for dedicated GHRP pharmacology research
• •No IGF-1 variants (DES or LR3) for insulin-like growth factor research
• •No Follistatin-344 or MGF for myostatin biology
• •PCL GLOW Blend format may not be suitable for all research designs

Verdict

Prime Peptides is the strongest choice in this review batch for researchers prioritizing the GLP receptor agonist spectrum. The $140 Retatrutide and the narrow $15 spread across all three GLP generations make it practical to procure all three simultaneously for comparative receptor pharmacology research — an option that is genuinely unusual in the domestic U.S. market.

The TB4-Frag 17-23 capsule format addresses a research design gap that few suppliers have recognized, making Prime Peptides the best single source for researchers specifically studying oral or alternative-delivery TB-500 biology. Combined with the competitive GHK-Cu bulk pricing and the KLOW blend rate, Prime Peptides delivers meaningful value across healing and longevity compound research categories.

The GHRP and IGF-1 gaps mean that researchers with dedicated growth hormone secretagogue or myostatin biology programs will need supplementary sourcing, but as a GLP-focused and blend-capable supplier, Prime Peptides is well-positioned.

---

For research purposes only. Not for human use. All products are sold exclusively for in-vitro laboratory research.

Internal links: Semaglutide • Tirzepatide • Retatrutide • TB-500 • BPC-157 • GHK-Cu • Compare suppliers